Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: FEBS J. 2012 Nov 22;280(1):127–138. doi: 10.1111/febs.12055

Table 1.

Phenotypes of RDS mutations characterized in this study.

Mutation Patient Phenotype Refs In Vitro/Murine Phenotype Refs
C150S N/A No intermolecular disulfide bonds
No formation of higher-order oligomeric complexes
Does not interact with ROM-1 in cones
Dominant-negative structural and functional degeneration in cones
[10, 22]
R172W Macular Dystrophy, Central Areolar Choroidal Dystrophy [38, 39, 50] Forms intermolecular disulfide bonds
Formation of normal complement of RDS complexes in vivo
Normal interactions with ROM-1
Dominant-negative structural and functional degeneration in cones.
[27, 28, 44]
C214S Autosomal Dominant Retinitis Pigmentosa [30] Forms aggregates in vitro
Does not interact with ROM-1 in vitro or in vivo.
Causes haploinsufficiency-like phenotype in vivo
[22, 29, 44]
N244H Macular Dystrophy [32] Forms intermolecular disulfide bonds
Normal interactions with ROM-1
Not studied in vivo
[43]
N244K Autosomal Dominant Retinitis Pigmentosa, Bull’s Eye Maculopathy, Cone-Rod Dystrophy [32, 40] Forms aggregates in vitro
Does not bind ROM-1
Not studied in vivo
[43]